Used as a key chiral intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system (CNS) agents and neuroactive drugs. Its fluorinated structure enhances metabolic stability and blood-brain barrier penetration, making it valuable in designing bioavailable therapeutics. Commonly employed in the preparation of selective enzyme inhibitors and receptor modulators, especially for targets related to psychiatric and neurological disorders. The stereochemistry supports high enantioselectivity in drug-receptor interactions, improving potency and reducing off-target effects.